Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$22.72 – $42.81
34% from low
Exchange
OTC Link
OS
KUROS BIOSCIENCE ORD NEW
No one on the platform currently holds CSBTF.
No tracked institution reports a position in CSBTF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-08-22 | 1-for-100reverse |
No one on the platform has traded CSBTF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $164M | +39.2% | $0.24 | $0.21–$0.26 | 124.5× | 1 |
| 2027 | $212M | +29.3% | $0.56 | $0.50–$0.61 | 53.0× | 1 |
| 2028 | $263M | +23.8% | $0.91 | $0.82–$1.00 | 32.5× | 1 |
| 2029 | $311M | +18.4% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CSBTFKuros Biosciences AG | $29.62 | +0.00% | $1.2B | — |
| ASCLFAscletis Pharma Inc. | $1.34 | +11.20% | $1.4B | — |
| CHIZFChina Traditional Chinese Medicine Holdings Co. Limited | $0.16 | +0.00% | $821M | — |
| CSPHFCStone Pharmaceuticals | $0.70 | +0.00% | $1.1B | — |
| MEOBFMesoblast Limited | $1.89 | +0.00% | $2.5B | — |
| NPPNYNippon Shinyaku Co., Ltd. | $5.71 | -6.55% | $1.5B |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| NURPFNeuren Pharmaceuticals Limited | $17.00 | +0.00% | $2.2B | — |